In This Edition

Key Takeaways

World leaders pledged environmental action, including a US pledge to halve emissions by 2050. Britain’s parliament passes motion calling China’s actions against Uighurs “genocide.” India again sets global record with over 300,000 new COVID-19 cases. Analysis: Science Under the Scope: Monoclonal Antibodies are an Effective Treatment for Immunocompromised Individuals.

Condition Updates

A rundown of important global developments in markets, in business, and region-by-region, as well as statistical risk assessments by country and by US state.

Science Under the Scope: Monoclonal Antibodies are an Effective Treatment for Immunocompromised Individuals

The arrival of the COVID-19 vaccine has ushered in a turning point in the pandemic. Many people can see the proverbial light at the end of the tunnel and are looking forward to moving into our post-COVID future. And while the vaccines have been remarkably effective, there is one group for which they have had little impact: immunocompromised individuals. 

Country in Charts: United States

More than 228.6 million vaccine doses have been administered across the nation. About 42.2 percent of the total US population have received 1 or more doses. The weekly average of new cases decreased this past week, with the current 7-day moving average of daily new cases (62,596) decreasing 10.1% compared with the previous 7 days.

Download the article